Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 12/2001

01-12-2001 | Article

Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB Prospective Complications Study

Authors: M. Porta, A.-K. Sjoelie, N. Chaturvedi, L. Stevens, R. Rottiers, M. Veglio, J. H. Fuller, and the EURODIAB Prospective Complications Study Group

Published in: Diabetologia | Issue 12/2001

Login to get access
Metadata
Title
Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB Prospective Complications Study
Authors
M. Porta
A.-K. Sjoelie
N. Chaturvedi
L. Stevens
R. Rottiers
M. Veglio
J. H. Fuller
and the EURODIAB Prospective Complications Study Group
Publication date
01-12-2001
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 12/2001
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s001250100030

Other articles of this Issue 12/2001

Diabetologia 12/2001 Go to the issue

Letter

The author's reply

Article

Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients

Article

Human adipose tissue glucose uptake determined using [18F]-fluoro-deoxy-glucose ([18F]FDG) and PET in combination with microdialysis

Article

Insulin-like growth factor 2 (IGF2 ) and IGF-binding protein 1 (IGFBP1) gene variants are associated with overfeeding-induced metabolic changes

Article

5-aminoimidazole-4-carboxy-amide-1-β-D-ribofuranoside treatment ameliorates hyperglycaemia and hyperinsulinaemia but not dyslipidaemia in KKAy-CETP mice

Article

Glucose-insulin-potassium treatment in combination with dipyridamole inhibits ischaemia-reperfusion-induced damage

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits